Subscribe To
10 buffett-style dividend aristocrat bargains you don't want to miss
Economists say the recession is canceled; the bond market is 98% sure it's still coming. The bond market is likely right, BUT history is very ...
November 4, 2023, 7:35 am
Palantir q3 earnings: focus on government contracts (rating upgrade)
Palantir Technologies reported strong Q3 2023 earnings, indicating significant upside potential for investors. Even after two decades in business, the...
November 4, 2023, 7:28 am
This dividend growth stock has a problem the market is missing right now
Fastenal's third-quarter earnings led to a 7.5% stock price advance on the day of the release. While Wall Street was ...
November 4, 2023, 6:06 am
10x genomics: unveiling the investment potential
10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Ge...
November 4, 2023, 1:02 am
The new question for the federal reserve: how long to keep rates high
Since the Federal Reserve started raising interest rates in its battle against inflation 18 months ago, the US central bank has made one thing ...
November 4, 2023, 12:59 am
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent ...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent ...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent ...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent ...
November 3, 2023, 11:30 pm
clearstar announces appointment of mike pritts as chief executive officer
New CEO brings a wealth of expertise to clearStar with over 35 years of senior leadership experience in...
November 3, 2023, 8:50 pm
Regional banks reeling from crisis; their etfs are holding on
The largest U.S. banks by asset size generally reported robust third-quarter earnings. Although for many of those banks, the strong results may not be...
November 3, 2023, 7:27 pm
Eurozone september unemployment rate 6.5% vs 6.4% expected
Prior was 6.4%The economy in Europe is clearly turning lower but this chart is a reminder of how laggy ...
November 3, 2023, 10:00 am
Eur/usd forecast: euro could test 1.0700 on a weak nfp print
EUR/USD went into a consolidation phase above 1.0600 early Friday. October Nonfarm Payrolls data could significantly influence the USD’s valuation. ...
November 3, 2023, 7:44 am
Apple lacks a clear path to growth this holiday season after four straight quarters of shrinkage
Apple indicated on Thursday that it doesn't expect revenue growth in the December quarter, which is the busiest time of the year...
November 2, 2023, 9:06 pm
What is a virtual power plant? an energy expert explains
By Daniel Cohan, Rice University After nearly two decades of stagnation, U.S. electricity demand is surging, driven by growing numbers of electric car...
November 2, 2023, 4:42 pm
clearway energy, inc. (cwen) q3 2023 earnings call transcript
clearway Energy, Inc. (CWEN) Q3 2023 Earnings Call Transcript...
November 2, 2023, 4:37 pm
Thd: beware of thailand's 'helicopter money' plans
Thailand's political overhang has finally cleared. Instead, markets will now have to contend with a fis...
November 2, 2023, 1:56 pm
clearside biomedical announces presentations at the american academy of ophthalmology 2023 annual meeting
– Clinical Data Utilizing clearside’s Suprachoroidal Delivery Technology to be Featured in Multiple...
November 2, 2023, 11:05 am
Gbp/usd forecast: pound sterling needs a hawkish boe to clear 1.2200
GBP/USD gathered bullish momentum and registered gains on Wednesday after dropping below 1.2100 earlier in the day. The pair continued to stretch high...
November 2, 2023, 9:29 am
Is alphabet a buy?
Alphabet's revenue and earnings beat expectations, but cloud revenue was a disappointment. The business is positioning itself to be a ...
November 2, 2023, 9:20 am